Your browser doesn't support javascript.
loading
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.
Trédan, O; Ménétrier-Caux, C; Ray-Coquard, I; Garin, G; Cropet, C; Verronèse, E; Bachelot, T; Rebattu, P; Heudel, P E; Cassier, P; Chabaud, S; Croughs, T; Dupont, P; Cadore, A C; Clapisson, G; Delgado, A; Bardin-dit-Courageot, C; Rigal, C; N'Kodia, A; Gilles-Afchain, L; Morre, M; Pérol, D; Blay, J Y; Caux, C.
  • Trédan O; Department of Medical Oncology, Leon Berard Cancer Center, Lyon Lyon University, Lyon ISPB, Lyon 1 University, Lyon CNRS UMR5286, Cancer Research Center of Lyon, Lyon.
  • Ménétrier-Caux C; Lyon University, Lyon ISPB, Lyon 1 University, Lyon CNRS UMR5286, Cancer Research Center of Lyon, Lyon Innovation in Immuno-monitoring and Immunotherapy Platform (P3I), Leon Berard Cancer Center Team 11, INSERM U1052, Cancer Research Center of Lyon, Lyon.
  • Ray-Coquard I; Department of Medical Oncology, Leon Berard Cancer Center, Lyon Lyon University, Lyon ISPB, Lyon 1 University, Lyon CNRS UMR5286, Cancer Research Center of Lyon, Lyon isabelle.ray-coquard@lyon.unicancer.fr.
  • Garin G; Clinical Research Platform (DRCI), Leon Berard Cancer Center, Lyon.
  • Cropet C; Clinical Research Platform (DRCI), Leon Berard Cancer Center, Lyon.
  • Verronèse E; Innovation in Immuno-monitoring and Immunotherapy Platform (P3I), Leon Berard Cancer Center.
  • Bachelot T; Department of Medical Oncology, Leon Berard Cancer Center, Lyon.
  • Rebattu P; Department of Medical Oncology, Leon Berard Cancer Center, Lyon.
  • Heudel PE; Department of Medical Oncology, Leon Berard Cancer Center, Lyon.
  • Cassier P; Department of Medical Oncology, Leon Berard Cancer Center, Lyon.
  • Chabaud S; Clinical Research Platform (DRCI), Leon Berard Cancer Center, Lyon.
  • Croughs T; Cytheris SA, Issy-Les-Moulineaux.
  • Dupont P; Clinical Research Platform (DRCI), Leon Berard Cancer Center, Lyon.
  • Cadore AC; Clinical Research Platform (DRCI), Leon Berard Cancer Center, Lyon.
  • Clapisson G; Biological Sample Management Platform (BB-0033-00050).
  • Delgado A; Innovation in Immuno-monitoring and Immunotherapy Platform (P3I), Leon Berard Cancer Center.
  • Bardin-dit-Courageot C; Innovation in Immuno-monitoring and Immunotherapy Platform (P3I), Leon Berard Cancer Center.
  • Rigal C; Innovation in Immuno-monitoring and Immunotherapy Platform (P3I), Leon Berard Cancer Center.
  • N'Kodia A; Innovation in Immuno-monitoring and Immunotherapy Platform (P3I), Leon Berard Cancer Center.
  • Gilles-Afchain L; Pharmacy, Leon Berard Cancer Center, Lyon.
  • Morre M; Revimmune, Paris, France.
  • Pérol D; Clinical Research Platform (DRCI), Leon Berard Cancer Center, Lyon.
  • Blay JY; Department of Medical Oncology, Leon Berard Cancer Center, Lyon Lyon University, Lyon ISPB, Lyon 1 University, Lyon CNRS UMR5286, Cancer Research Center of Lyon, Lyon Team 11, INSERM U1052, Cancer Research Center of Lyon, Lyon.
  • Caux C; Lyon University, Lyon ISPB, Lyon 1 University, Lyon CNRS UMR5286, Cancer Research Center of Lyon, Lyon Innovation in Immuno-monitoring and Immunotherapy Platform (P3I), Leon Berard Cancer Center Team 11, INSERM U1052, Cancer Research Center of Lyon, Lyon.
Ann Oncol ; 26(7): 1353-62, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25851629
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Interleucina-7 / Carcinoma Lobular / Carcinoma Ductal de Mama / Linfopenia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Interleucina-7 / Carcinoma Lobular / Carcinoma Ductal de Mama / Linfopenia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2015 Tipo del documento: Article